The Morning Call
A significant breakthrough may have been recorded in the search for effective treatment and cure for the deadly HIV virus. Scientists say a new HIV vaccine candidate has been trialled in humans and monkeys, with promising results.
Nearly 400 healthy, uninfected adults are reported to have mounted an immune response against the vaccine and tolerated it well, according to the latest study published in The Lancet.
It’s a quest that’s been nearly 40 years in the making. Lead researcher Dan Barouch from Harvard Medical School said the study was an “important milestone” in HIV research, but that the results should be interpreted with caution.
So are we one step closer to finding effective treatment for HIV?
01:36
Iran war shipping disruption impacts medicine availability in Sudan
Go to video
Demand surges in Nigeria for new HIV prevention injection ahead of rollout
Go to video
South Africa pushes for local production of HIV prevention drug lenacapavir
02:16
Kenya rolls out twice-yearly HIV prevention shot in Nairobi slum
02:28
Zimbabwe roll-out of long-acting HIV prevention drug gets underway
01:01
Zimbabwe launches groundbreaking HIV prevention drug Lenacapavir